Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
SIMPRE
Abandoned - No Statement Of Use F…
Show more
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of multiple myeloma
Class 5 – Pharmaceuticals & supplements
Status timeline
- 15 Dec 2023Application filedNew Application Entered
- 11 Jul 2024Assigned to an examining attorneyAssigned To Examiner
- 13 Jul 2024Office action issuedNon-Final Action Written
- 15 Jul 2024Approved for publicationApproved For Pub - Principal Register
- 20 Aug 2024Published for oppositionPublished For Opposition
- 15 Oct 2024Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 24 Feb 2025Statement-of-use extension 1 grantedSou Extension 1 Granted
- 17 Nov 2025Application abandoned — no statement of use filedAbandonment - No Use Statement Filed
All 25 events
| 2025-11-17 | Abandonment - No Use Statement Filed |
| 2025-11-17 | Abandonment Notice Mailed - No Use Statement Filed |
| 2025-06-30 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2025-06-30 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2025-06-30 | Teas Change Of Domestic Representatives Address |
| 2025-06-30 | Teas Change Of Correspondence Received |
| 2025-06-30 | Teas Withdrawal Of Attorney Received-Firm Retains |
| 2025-02-24 | Sou Teas Extension Received |
| 2025-02-24 | Sou Extension 1 Filed |
| 2025-02-24 | Sou Extension 1 Granted |
| 2025-02-24 | Notice Of Approval Of Extension Request E-Mailed |
| 2024-10-15 | Noa Mailed - Sou Required From Applicant |
| 2024-08-20 | Published For Opposition |
| 2024-08-20 | Official Gazette Publication Confirmation E-Mailed |
| 2024-07-31 | Notification Of Notice Of Publication E-Mailed |
| 2024-07-15 | Approved For Pub - Principal Register |
| 2024-07-13 | Non-Final Action Written |
| 2024-07-13 | Non-Final Action E-Mailed |
| 2024-07-13 | Notification Of Non-Final Action E-Mailed |
| 2024-07-11 | Assigned To Examiner |
| 2024-06-26 | Assigned To Lie |
| 2024-06-26 | Preliminary/Voluntary Amendment - Entered |
| 2024-01-26 | New Application Office Supplied Data Entered |
| 2023-12-27 | Teas Voluntary Amendment Received |
| 2023-12-15 | New Application Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of multiple myeloma
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 17 Nov 2025; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.